Ono Pharmaceutical CoMEX:4528N 88 Pretax Margin % is 2.76% as of Mar. 2026, which is 90% below its 10-year median of 28.16. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review. Among 952 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 77.21% on this metric.
The historical rank and industry rank for Ono Pharmaceutical Co's Pretax Margin % or its related term are showing as below:
MEX:4528N'
s Pretax Margin % Range Over the Past 10 Years
Min: 12.19 Med: 28.16 Max: 32.62
Current: 17.96
MEX:4528N's Pretax Margin % is ranked better than 77.21% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs MEX:4528N: 17.96
Ono Pharmaceutical Co (MEX:4528N) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Ono Pharmaceutical Co Pretax Margin % Related Terms
Ono Pharmaceutical Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:4528N vs LLY, JNJ, ABBV: Pretax Margin % Comparison
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (MEX:4528N) has a Pretax Margin % of 2.76% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ono Pharmaceutical Co and its competitors. This is 90% below median its historical median of 28.16. Over the past decade, Ono Pharmaceutical Co's Pretax Margin % has ranged from 12.19 to 32.62. According to the industry distribution chart, Ono Pharmaceutical Co ranks #217 out of 952 companies in the Drug Manufacturers industry, placing it in the top 22.8%.
Is Ono Pharmaceutical Co's Pretax Margin % too high?
Ono Pharmaceutical Co's current Pretax Margin % of 2.76% is 90% below median its 10-year median of 28.16. Over the past 10 years, this metric has ranged from a low of 12.19 to a high of 32.62. The Drug Manufacturers industry median Pretax Margin % is 7.30. Ono Pharmaceutical Co's value of 2.76% is 62.2% below this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #217 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Pretax Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #217 out of 952 companies for Pretax Margin %. This places Ono Pharmaceutical Co in the top 23% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.30. Ono Pharmaceutical Co's value of 2.76% is 62.2% below this benchmark. Historically, Ono Pharmaceutical Co's own Pretax Margin % has ranged from 12.19 to 32.62 over the past decade. While the company's 10-year median is 28.16 vs. the industry median of 7.30, Ono Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current Pretax Margin % of 2.76% is 62.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current Pretax Margin % is 2.76%, which is 90% below median its own 10-year median of 28.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Pretax Margin % of 2.76%. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current Pretax Margin % is 2.76%, which is 90% below median its 10-year median of 28.16 and 62.2% below the Drug Manufacturers industry median of 7.30. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Pretax Margin % is 2.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.
Key valuation signals for MEX:4528N:
Pretax Margin %: 2.76% (90% below median its 10-year median of 28.16)
GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
Industry Position: 62.2% below the Drug Manufacturers median (#217 of 952)
No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score
Get the complete analysis for MEX:4528N
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4528N has been successfully added to your 
